CECILIA WILLE: Open Payments
NPI 1215488770 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 6 payments from 6 companies in 2025. Trend: 2023 $346 · 2024 $431 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 1 | $192 |
| Galderma Laboratories, L.P. | 1 | $140 |
| Edwards Lifesciences Corporation | 1 | $137 |
| Novartis Pharmaceuticals Corporation | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $70 |
Products named: FFRct, NEMLUVIO, SAPIEN 3 Ultra RESILIA, LEQVIO, Repatha, Wegovy.
Industry payments across CA — which companies pay providers there.
